Humana Inc. closed 37.25% below its 52-week high of $406.46, which the company reached on July 18th.

Just over 34.4 million people were enrolled in Medicare Advantage (MA) plans as of Feb. 1, representing fairly slim growth ...

Enrollment in private Medicare Advantage plans grew just 3.1%, below projections from Wall Street or the government.

We've got to be more creative in keeping major companies or we'll just sit and watch one company after another get picked off ...

The CMS released highly anticipated MA enrollment data on Tuesday that showed UnitedHealth further tightening its grip on the ...

Humana (HUM) introduced a new value-based care agreement with Thyme Care to provide comprehensive cancer care support for eligible Humana ...

UnitedHealth Group, Humana and Cigna are investing in artificial intelligence tools amid lawsuits over their alleged use of ...

US managed care insurers' Q4 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to ...

Shares of Humana Inc. HUM advanced 1.67% to $259.27 Tuesday, on what proved to be an all-around mixed trading session for the ...

Following strong gains in Q3, the Russell 1000® Value Index finished slightly lower in Q4, declining -1.98%. For the year, ...

Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.

Humana Inc. (NYSE:HUM – Get Free Report) has earned an average recommendation of “Hold” from the twenty-four analysts that ...